abstract |
The subject of the present invention is the different polymorphic forms I, II, III, IV of (S, S) -2- (2-acetylsulfanylmethyl-3-benzo [1,3] dioxol-5-ylpropionylamino) benzyl propionate, ci -after called Fasidotril, their preparation processes and the new pharmaceutical compositions which contain them. |